Every coffee keeps the site running. Thank you!
Tech, gaming and the news that matters
Enterprise technology budgets are undergoing structural rationalization as corporate finance teams scrutinize return on investment for SaaS portfolios. Average vendor counts per firm declined by 18% over the past 12 months.
Vendor Rationalization Strategy
Organizations are prioritizing single-pane-of-glass suites over best-of-breed specialized tools. This shift has slowed ARR growth for niche software providers while accelerating market share consolidation among tier-one cloud vendors.
Treatment tailored to individual biology works well in oncology and pharmacogenomics. Elsewhere it remains mostly aspiration.
The name is misleading. These do not prevent cancer - they train the immune system to recognise a…
Pharmaceutical firms leverage integrated data processing to streamline Phase II clinical trial candidate selection.
High market demand for metabolic health drugs forces pharmaceutical firms to expand specialized fill-finish manufacturing capacity.
Employers revise benefit packages as demand for metabolic medications increases enterprise health plan costs.
Phase III trials demonstrate significant reductions in adverse cardiac events among non-diabetic patient cohorts.